BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2500613)

  • 1. Massive systemic amyloidosis associated with light-chain deposition disease.
    Troussard X; Hurault de Ligny B; Gallet B; Ganeval D; Mandard JC; Ryckelynck JP; Leporrier M
    Nephron; 1989; 52(2):139-43. PubMed ID: 2500613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic kappa light chain deposition and amyloidosis in multiple myeloma: novel morphological observations.
    Kirkpatrick CJ; Curry A; Galle J; Melzner I
    Histopathology; 1986 Oct; 10(10):1065-76. PubMed ID: 3096869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association light chain deposition disease (LCDD) and amyloidosis. One case.
    Hofmann-Guilaine C; Nochy D; Jacquot C; Tricottet V; Bariety J; Camilleri JP
    Pathol Res Pract; 1985 Aug; 180(2):214-9. PubMed ID: 3932985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
    Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
    Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light-chain deposition disease: its relation with AL-type amyloidosis.
    Ganeval D; Noël LH; Preud'homme JL; Droz D; Grünfeld JP
    Kidney Int; 1984 Jul; 26(1):1-9. PubMed ID: 6434789
    [No Abstract]   [Full Text] [Related]  

  • 6. Unusual findings in a myeloma kidney: a light- and electron-microscopic study.
    Lam KY; Chan KW
    Nephron; 1993; 65(1):133-6. PubMed ID: 8413771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe intrahepatic cholestasis and rapidly progressive renal failure in a patient with immunocyte-related amyloidosis.
    Skander MP; Harry DS; Lee FI
    J Clin Gastroenterol; 1987 Apr; 9(2):219-22. PubMed ID: 3106463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
    Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
    Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two autopsy cases with systemic amyloidosis--case 11/2010].
    Schott S; Artunc F; Haap M; Mackensen-Haen S; Fend F; Riessen R
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2186. PubMed ID: 20979003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
    Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
    Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic immunoglobulin light-chain amyloidosis presenting hematochezia as the initial symptom.
    Kon T; Nakagawa N; Yoshikawa F; Haba K; Kitagawa N; Izumi M; Kumazaki S; Ishida S; Aikawa R
    Clin J Gastroenterol; 2016 Aug; 9(4):243-51. PubMed ID: 27318996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
    Iványi B
    Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congo red-positive cardiac kappa-AL amyloidosis in plasmacytoma -- case report and review of the literature.
    Tzankov A; Pölzl G; Mairinger T
    Acta Med Austriaca; 2003; 30(1):29-32. PubMed ID: 12558564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
    Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
    Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient.
    Grassi MP; Clerici F; Perin C; Borella M; Gendarini A; Quattrini A; Nemni R; Mangoni A
    Ital J Neurol Sci; 1998 Aug; 19(4):229-33. PubMed ID: 10933463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of amyloidosis complicated by IgU/lambda/-myeloma multiplex].
    Husz S; Török L; Kovács L; Szabó E; Simon N
    Z Hautkr; 1979 Jul; 54(13):585-9. PubMed ID: 113946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse parenchymal amyloidosis of lungs and breast. Its association with diffuse plasmacytosis and kappa-chain gammopathy.
    Hardy TJ; Myerowitz RL; Bender BL
    Arch Pathol Lab Med; 1979 Oct; 103(11):583-5. PubMed ID: 114145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorescence study of "non-idiopathic" renal amyloidosis.
    Orfila C; Rakotoarivony J; Segonds A; Suc JM
    Hum Pathol; 1983 Apr; 14(4):362-7. PubMed ID: 6403452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.